Sarepta Therapeutics, Inc. (SRPT): Price and Financial Metrics
Sarepta Therapeutics, Inc. (SRPT)
Today's Latest Price: $94.67 USD
1.67 (1.80%)
Updated Apr 2 10:35am
Add SRPT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
SRPT Stock Summary
- Of note is the ratio of Sarepta Therapeutics Inc's sales and general administrative expense to its total operating expenses; merely 14.23% of US stocks have a lower such ratio.
- With a price/sales ratio of 18.94, Sarepta Therapeutics Inc has a higher such ratio than 94.52% of stocks in our set.
- In terms of twelve month growth in earnings before interest and taxes, Sarepta Therapeutics Inc is reporting a growth rate of 107.75%; that's higher than 89.63% of US stocks.
- Stocks that are quantitatively similar to SRPT, based on their financial statements, market capitalization, and price volatility, are PTCT, MTEM, VBIV, KPTI, and RMBS.
- SRPT's SEC filings can be seen here. And to visit Sarepta Therapeutics Inc's official web site, go to www.sarepta.com.
SRPT Daily Price Range
SRPT 52-Week Price Range
SRPT Stock Price Chart More Charts
SRPT Price/Volume Stats
| Current price | $94.67 | 52-week high | $158.80 |
| Prev. close | $93.00 | 52-week low | $72.05 |
| Day low | $91.53 | Volume | 177,662 |
| Day high | $94.63 | Avg. volume | 914,777 |
| 50-day MA | $109.59 | Dividend yield | N/A |
| 200-day MA | $111.73 | Market Cap | 7.36B |
Sarepta Therapeutics, Inc. (SRPT) Company Bio
Sarepta Therapeutics is a biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare, infectious and other diseases. The company was founded in 1980 and is based in Cambridge, Massachusetts.
Loading social stream, please wait...